Skip to main content

Table 12 CN distribution of proteins consistently expressed in cancer samples

From: Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery

Type of cancer # proteins Zone 1 Zone 2 Zone 3 Zone 4 Zone 5
Breast 350 24 (6.8%) 224 (64%) 95 (27.1%) 7 (2%) -
Cervical 760 43 (5.6%) 496 (65.2%) 203 (26.7%) 16 (2.1%) 2 (0.2%)
Endometrial 1644 91 (5.5%) 1007 (61.2%) 474 (28.8%) 61 (3.7%) 11 (0.6%)
Fallopian 1408 71 (5%) 869 (61.7%) 409 (29%) 51 (3.6%) 8 (0.5%)
Glioblastoma 1128 63 (5.5%) 719 (63.7%) 311 (27.5%) 30 (2.6%) 5 (0.4%)
Glioma 1270 67 (5.2%) 765 (60.2%) 380 (29.9%) 48 (3.7%) 10 (0.7%)
Kidney 593 44 (7.4%) 389 (65.5%) 150 (25.2%) 10 (1.6%) -
Liver 769 51 (6.6%) 475 (61.7%) 221 (28.9%) 21 (2.7%) 1 (0.1%)
Lung 571 39 (6.8%) 369 (64.6%) 153 (26.7%) 9 (1.5%) 1 (0.1%)
Ovarian 823 37 (4.4%) 524 (63.6%) 236 (28.6%) 23 (2.7%) 3 (0.3%)
Pancreatic 771 44 (5.7%) 483 (62.6%) 223 (28.9%) 21 (2.7%) -
Pituitary 1228 60 (4.8%) 738 (60%) 373 (30.3%) 47 (3.8%) 10 (0.8%)
Rectal 1753 96 (5.4%) 1061 (60.5%) 515 (29.3%) 70 (3.9%) 11 (0.6%)
Average   5.7% 62.7% 28.2% 2.8% 0.3%